Complement inhibition keeps mothers calm and avoids fetal rejection (Q37248466)

19 August 2017

1 reference

title

Complement inhibition keeps mothers calm and avoids fetal rejection (English)

1 reference

19 August 2017

Guillermina Girardi

1

0 references

publication date

1 January 2008

1 reference

Immunological Investigations

19 August 2017

1 reference

19 August 2017

37

1 reference

19 August 2017

5

1 reference

19 August 2017

645-659

1 reference

Actively acquired tolerance of foreign cells

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Intercellular adhesion molecule-1/LFA-1 cross talk is a proximate mediator capable of disrupting immune integration and tolerance mechanism at the feto-maternal interface in murine pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Management of the obstetric antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

The interactions between inflammation and coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Intrauterine nutrition: its importance during critical periods for cardiovascular and endocrine development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Control of the complement system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Complement-targeted therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Glucose tolerance, insulin sensitivity, and insulin secretion in children born small for gestational age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Complement. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Complement. Second of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

New concepts of complement in allorecognition and graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

A critical role for murine complement regulator crry in fetomaternal tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

Paediatric consequences of fetal growth restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130802191615

10.1080/08820130802191615

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18716942